本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

79.24
-0.5400-0.68%
盘前:78.40-0.8400-1.06%08:58 EDT
成交量:34.09万
成交额:2,716.71万
市值:61.83亿
市盈率:80.04
高:80.99
开:80.00
低:78.82
收:79.78
52周最高:82.94
52周最低:35.20
股本:7,802.40万
流通股本:3,994.15万
量比:0.86
换手率:0.85%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
净资产收益率:14.04%
总资产收益率:8.05%
市净率:9.45
市盈率(LYR):105.65

数据加载中...

2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/09

SEC问询函

Form CORRESP - Correspondence
2023/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

SEC问询函

Form CORRESP - Correspondence
2023/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/31

重要事件披露

Form 8-K - Current report
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/25

重要事件披露

Form 8-K - Current report
2023/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/07

重要事件披露

Form 8-K - Current report
2023/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/02

重要事件披露

8-K - Current report